{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04921917",
            "orgStudyIdInfo": {
                "id": "Pro00093033"
            },
            "organization": {
                "fullName": "Duke University",
                "class": "OTHER"
            },
            "briefTitle": "Exercise and Soft Tissue Sarcoma",
            "officialTitle": "The Effect of Exercise on Patient Outcomes During Treatment of Soft Tissue Sarcoma With Neoadjuvant Radiation Therapy and Surgical Resection",
            "therapeuticArea": [
                "Other"
            ],
            "study": "exercise-and-soft-tissue-sarcoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-04-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-18",
            "studyFirstSubmitQcDate": "2021-06-04",
            "studyFirstPostDateStruct": {
                "date": "2021-06-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Duke University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "University of North Carolina, Chapel Hill",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment."
        },
        "conditionsModule": {
            "conditions": [
                "Soft Tissue Sarcoma"
            ],
            "keywords": [
                "exercise",
                "soft tissue sarcoma",
                "STS"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "This study is partially blinded. The wound surveyor and statistician(s) will be blinded to the treatment groups.",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control",
                    "type": "NO_INTERVENTION",
                    "description": "Standard of care: neoadjuvant radiation therapy (NRT)."
                },
                {
                    "label": "Neoadjuvant Exercise Regimen",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will receive conventional NRT in conjunction with a prescribed exercise regimen during the usual 10-week duration of NRT treatment prior to tumor resection.",
                    "interventionNames": [
                        "Other: neoadjuvant exercise therapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "neoadjuvant exercise therapy",
                    "description": "brief exercise regimen completed immediately prior to neoadjuvant radiation therapy. Rubber bands will be used for the exercise training of patients with lower extremity tumors while an electronic hand-held dynamometer will be used for the exercise training for patients with upper extremity tumors.",
                    "armGroupLabels": [
                        "Neoadjuvant Exercise Regimen"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of patients with a wound complication after surgery as measured by wound complication form",
                    "description": "The wound complication form is a team developed form that asks about different complications that can arise after surgery. These complications include delayed wound healing, surgical site or periprosthetic infection, re-operation, and other invasive procedures necessitated by wound complications.",
                    "timeFrame": "Up to 24 weeks post-op"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percent necrosis of tumor",
                    "description": "Percent necrosis at the time of tumor resection",
                    "timeFrame": "During surgery"
                },
                {
                    "measure": "Number of inflammatory serum markers",
                    "description": "Number of inflammatory serum markers as assessed by CRP, Complete Blood Count, and ESR.",
                    "timeFrame": "First day of NRT"
                },
                {
                    "measure": "Number of inflammatory serum markers",
                    "description": "Number of inflammatory serum markers as assessed by CRP, Complete Blood Count, and ESR.",
                    "timeFrame": "Halfway through NRT (up to 5 weeks of NRT)"
                },
                {
                    "measure": "Number of inflammatory serum markers",
                    "description": "Number of inflammatory serum markers as assessed by CRP, Complete Blood Count, and ESR.",
                    "timeFrame": "Last day of NRT (up to 10 weeks of NRT)"
                },
                {
                    "measure": "Tissue Perfusion",
                    "description": "Tissue Perfusion using the Near Infra-Red (NIRS) system",
                    "timeFrame": "6-week post-op"
                },
                {
                    "measure": "The Musculoskeletal Tumor Society (MSTS) score",
                    "description": "The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.",
                    "timeFrame": "At enrollment."
                },
                {
                    "measure": "The Musculoskeletal Tumor Society (MSTS) score",
                    "description": "The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.",
                    "timeFrame": "2 weeks or less prior to surgery"
                },
                {
                    "measure": "The Musculoskeletal Tumor Society (MSTS) score",
                    "description": "The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.",
                    "timeFrame": "6-week post-op"
                },
                {
                    "measure": "Edmonton Symptom Assessment System (ESAS) - Sarcoma Modified (SM) quality of life questionnaire",
                    "description": "The Edmonton Symptom Assessment System - Sarcoma Modified (ESAS-SM) questionnaire on quality of life. The total score ranges from 0 to 110, with lower scores indicating better quality of life.",
                    "timeFrame": "At enrollment"
                },
                {
                    "measure": "Edmonton Symptom Assessment System (ESAS) - Sarcoma Modified (SM) quality of life questionnaire",
                    "description": "The Edmonton Symptom Assessment System - Sarcoma Modified (ESAS-SM) questionnaire on quality of life. The total score ranges from 0 to 110, with lower scores indicating better quality of life.",
                    "timeFrame": "2 weeks or less prior to surgery"
                },
                {
                    "measure": "Edmonton Symptom Assessment System (ESAS) - Sarcoma Modified (SM) quality of life questionnaire",
                    "description": "The Edmonton Symptom Assessment System - Sarcoma Modified (ESAS-SM) questionnaire on quality of life. The total score ranges from 0 to 110, with lower scores indicating better quality of life.",
                    "timeFrame": "6-week post-op"
                },
                {
                    "measure": "Surgical Wound Assessment Form",
                    "description": "Wound assessment and healing tracker tool created by the study team. The total score ranges from 13 to 65, with lower scores indicating better wound healing.",
                    "timeFrame": "Up to 24 weeks post-op"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Males and females within the ages of 18-85\n2. Diagnosis of soft tissue sarcoma that has been histologically confirmed by an approved reference pathologist\n3. Sarcoma of the upper or lower extremity location\n4. Treatment plan that includes neo-adjuvant radiation therapy followed by surgical resection\n5. Expected primary wound closure performed at the time at surgery\n6. Any disease stage\n7. Any tumor grade\n8. Any histologic subtype\n9. First or recurrent presentations\n10. No vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity\n11. No history of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied\n12. Must be able to comply with follow up visits\n13. Must be able to provide own consent\n\nExclusion Criteria:\n\n1. Patients under the age of 18, or over the age of 85\n2. Treatment plan that does not include neo-adjuvant radiation and surgical excision\n3. Sarcoma location other than the upper or lower extremity\n4. History of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied\n5. High dose steroid therapy (defined as \\>5mg prednisone, or equivalent, with the last 30 days)\n6. Active treatment with chemotherapy within the last 30 days\n7. Inability of the patient to provide informed consent (i.e. dementia, cognitive impairment, non-English speakers)\n8. Plan for post-operative radiation therapy\n9. Underlying severe cardiopulmonary disease\n10. Prior surgery, other than a biopsy, at the site of disease\n11. Tumors that are ulcerative or fungating through the dermis at the time of presentation\n12. Vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity\n13. Vascular disease resulting in clinically apparent compromise in blood flow to the treatment extremity (i.e. peripheral vascular disease with diminished pulses, venous insufficiency with clinical evidence of vascular congestion)\n14. Actively uncontrolled diabetes mellitus (documentation of history of Diabetes with A1c\\>8)\n15. Active deep vein thrombosis in the treatment extremity\n16. Inability to comply with follow up visits\n17. Pregnant females (women of childbearing potential must have a negative serum pregnancy test prior to enrollment)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Elizabeth Sachs, MS",
                    "role": "CONTACT",
                    "phone": "919-660-9849",
                    "email": "elizabeth.sachs@duke.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "William Eward, DVM, MD",
                    "affiliation": "Duke Orthopedic Oncology",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Duke University",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "William Eward, DVM, MD",
                            "role": "CONTACT",
                            "phone": "919-613-5550",
                            "email": "william.eward@duke.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012509",
                    "term": "Sarcoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018204",
                    "term": "Neoplasms, Connective and Soft Tissue"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "asFound": "Soft Tissue Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18592",
                    "name": "Ichthyosis, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M20350",
                    "name": "Neoplasms, Connective and Soft Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "asFound": "Soft Tissue Sarcoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}